生物
表观遗传学
DNA甲基化
CpG站点
癌症研究
染色质
重编程
染色质重塑
甲基化
小细胞癌
表观遗传学
病理
恶性肿瘤
电池类型
表型
清除单元格
免疫组织化学
谱系(遗传)
卵巢
杂合子丢失
视网膜母细胞瘤蛋白
溴尿嘧啶
癌
作者
Sarah-Slim Diwan,Gaëlle Akiki,Felix K. F. Kommoss,Céline Domecq,Leora Witkowski,Friedrich Kommoss,Yemin Wang,Sidong Huang,Dmitriy Zamarin,Anthony Nicholas Karnezis,David Byron Chapel,Amir Momeni Boroujeni,Vincent Quoc‐Huy Trinh,David G. Huntsman,Wilson Glenn McCluggage,Íñigo Espinosa,William D. Foulkes,Basile Tessier‐Cloutier
标识
DOI:10.1016/j.modpat.2026.101117
摘要
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive malignancy defined by inactivation of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex, specifically SMARCA4. It predominantly affects adolescent and young women, with poor survival despite radical surgery and multi-agent chemotherapy. Novel targeted agents have emerged with variable success. Here, we show that DNA methylation profiling stratifies SCCOHT (n= 63) into two distinct clusters with different morphologies: SCCOHT-1 exhibits typical features, including small cells and follicle-like spaces, while SCCOHT-2 exhibits large cells and rhabdoid morphology. Despite these differences, both clusters showed low copy number variation burden, reinforcing SWI/SNF deficiency as the central oncogenic driver. Differential methylation analysis revealed CpG island hypermethylation and open sea hypomethylation in SCCOHT-2, consistent with reprogramming of promoter and enhancer compartments. These epigenetic states were mirrored by distinct chromatin regulator signatures, differentiation programs, and calcium-regulatory networks. Immunohistochemistry further delineated the subtypes: WT1 was negative in SCCOHT-2, whereas it was diffusely expressed in SCCOHT-1. Keratins and cyclin D1 showed the opposite profile and were absent in SCCOHT-1. p16 was abnormal in both clusters: it was diffusely expressed in SCCOHT-2 and absent in SCCOHT-1. Clinically, both subtypes presented at a young age and were aggressive; however, hypercalcemia was restricted to SCCOHT-1. These findings establish SCCOHT heterogeneity despite uniform SWI/SNF ATPase loss, with implications for lineage specification and therapeutic stratification.
科研通智能强力驱动
Strongly Powered by AbleSci AI